Professional Documents
Culture Documents
Symptomatic or High-Risk Individual: Figure 1. Diagnosis of Acute Hepatitis
Symptomatic or High-Risk Individual: Figure 1. Diagnosis of Acute Hepatitis
Symptomatic or High-Risk Individual: Figure 1. Diagnosis of Acute Hepatitis
Because HCV Ab may not be detectable for several months after infection, HCV Ab-negative patients with suspected recent exposure (<6 months) should
receive HCV RNA testing or follow-up testing for HCV antibody. HCV RNA testing may also be appropriate for immunocompromised individuals. For HCV Ab-
positive/HCV RNA-negative patients, testing with another HCV antibody assay can be considered to differentiate resolved HCV infection from biologic false
positivity for HCV Ab; patients with clinical evidence of HCV infection or suspected recent exposure should be retested for HCV RNA; retesting may also be
considered if sample mishandling is suspected. HAV indicates hepatitis A virus; HBc IgM Ab, hepatitis B core IgM antibody; HBsAg, hepatitis B surface antigen;
HCV, hepatitis C virus; and HDV, hepatitis D virus.
This figure was developed by Quest Diagnostics and is based in part on references 12, 14, 15, and 16. It is provided for informational purposes only and is not
intended as medical advice. A physicians test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education,
clinical expertise, and assessment of the patient.
Quest, Quest Diagnostics, any associated logos, and all Content reviewed 02/2016
associated Quest Diagnostics registered or unregistered
trademarks are the property of Quest Diagnostics. All third-party
marks and are the property of their respective owners.
2016 Quest Diagnostics Incorporated. All rights reserved.